MangoRx — NAD+ route, dose and price
MangoRx is not a partner — this company pays us nothing, and it is listed anyway.
MangoRx publishes a floor only for NAD+, across 1 distinct figure read from its own page.
1 figure, by route
| Route | Dose | Price |
|---|---|---|
| Route not stated | dose not stated | $200Monthly |
advertised floor for something the seller does not name The page says 'injectable' but never says subcutaneous, intramuscular or intravenous — in the visible text or in the collapsed FAQ — so the route is left unspecified with the seller's own 'injectable' sentence quoted. No strength, volume or supply period is published.
| ||
We are paid nothing if you sign up here.
What else the page states
- Routes this seller names
- None. Every figure on this seller's page carries no route at all — the seller's own silence, not a gap in the data.
- Where the link goes
- Straight to this company's own NAD+ page.
Where MangoRx sits
On the full roster it is row 51 of 106. That roster is ordered by what each seller states about its own figures and by nothing else — payment changes neither a price recorded here nor where a row sits.
We are paid nothing if you sign up here.
Prices move. Everything above was read on September 2026 and is republished with that date attached; check MangoRx’s own page before you buy.